Mivacurium.
The muscle relaxant mivacurium was introduced in 1988 as a non-depolarizing drug with the pharmacokinetic profile of suxamethonium. Like suxamethonium, mivacurium is hydrolyzed by plasma cholinesterase; however, it has proved to be slower in onset and considerably longer in its duration of action. Inspite of this, in clinically used doses, it is somewhat shorter acting than alternative non-depolarizing drugs.
Feldman
S
S
Department of Anaesthetics, Charing Cross and Westminster Medical School, Chelsea and Westminster Hospital, London.
D002802:Cholinesterases / Q000378:metabolism; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D000077590:Mivacurium; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*
D004304:Dosage Forms; D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D000077590:Mivacurium; D002802:Cholinesterases